M, A., V, T., C, A., S, R., A, B., E, P., . . . G, V. (2024). How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: A review of literature. Frontiers in oncology, 14, 1335196. https://doi.org/10.3389/fonc.2024.1335196
Chicago Style (17th ed.) CitationM, Arcieri, et al. "How BRCA and Homologous Recombination Deficiency Change Therapeutic Strategies in Ovarian Cancer: A Review of Literature." Frontiers in Oncology 14 (2024): 1335196. https://doi.org/10.3389/fonc.2024.1335196.
MLA (9th ed.) CitationM, Arcieri, et al. "How BRCA and Homologous Recombination Deficiency Change Therapeutic Strategies in Ovarian Cancer: A Review of Literature." Frontiers in Oncology, vol. 14, 2024, p. 1335196, https://doi.org/10.3389/fonc.2024.1335196.